EUVIMEDEUVIMED entdecken
Crossref

Exploring the therapeutic potential of Anoectochilus roxburghii in glucose and lipid metabolism disorder: From phenotypic effects to molecular mechanisms and network pharmacology

Wei Li, Yaqian Cheng, Tong Wu, Chenning Zhao, Qingsong Shao, Lanying Pan, Ying Zheng

Journal of Pharmaceutical and Biomedical Analysis · 2026

DOI: 10.1016/j.jpba.2026.117360 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmaceutical and Biomedical Analysis, 2026. Verfasst von Wei Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: National Key Laboratory for Development and Utilization of Forest Food Resources, Zhejiang A&F University, Hangzhou 311300, China; Zhejiang Provincia…. Hauptthemen laut MEDLINE: Orchidaceae, Lipid Metabolism, Drugs, Chinese Herbal, Hypoglycemic Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: Key Research and Development Program of Sichuan Province, Fundamental Research Funds for the Provincial Universities of Zhejiang, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dysregulation of glucose and lipid metabolism has emerged as a leading cause of cardiovascular diseases worldwide. The current treatment for these diseases is often a combination of drugs. Despite the preference efficacy of combination therapies, adverse reactions have been frequently reported, such as gastrointestinal bleeding. Anoectochilus roxburghii (Wall.) Lindl., one of the traditional Chinese medicines, is recognized for its hypolipidemic and hypoglycemic effects. However, the exact therapeutic potential of A. roxburghii in glucose and lipid metabolism remains unsolved. By employing in vitro and in vivo experiments, this study evaluated the pharmacological activities of A. roxburghii and identified the primary active compounds involved in glucose and lipid metabolism. The results indicated that A. roxburghii can ameliorate dysregulation in glucose and lipid metabolism by promoting glycogen synthesis, and inhibiting gluconeogenesis and fatty acid oxidation. Using UHPLC-QE-MS, a total of 662 compounds were detected in the aqueous extract of A. roxburghii, and 769 were identified in the ethanol extract. Key ingredients such as morin and kaempferol participated in glucose metabolism, while kinsenoside and naringenin modulating lipid metabolism. Furthermore, A. roxburghii may potentially intervene in the insulin resistance signaling pathway by influencing TP53 protein expression, thereby modulating glucose metabolism process. This research provides evidence for the development and application of A. roxburghii as potential drugs in the treatment of glucose and lipid disordered diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OrchidaceaeLipid MetabolismDrugs, Chinese HerbalHypoglycemic AgentsGlucosePlant ExtractsGlucose Metabolism DisordersHypolipidemic AgentsAnimalsNetwork PharmacologyChromatography, High Pressure LiquidHumansGluconeogenesisMice

Stichwörter der Autor:innen

Anoectochilus roxburghiiGlycolipid metabolismMolecular mechanismNetwork pharmacology

Substanzen

Drugs, Chinese HerbalHypoglycemic AgentsGlucosePlant ExtractsHypolipidemic Agents

Autor:innen und Institutionen

  • National Key Laboratory for Development and Utilization of Forest Food Resources, Zhejiang A&F University, Hangzhou 311300, China; Zhejiang Provincial Key Laboratory of Resources Protection and Innovation of Traditional…
  • Key Laboratory of Artificial Organs and Computational Medicine in Zhejiang Province, Shulan International Medical College, Zhejiang Shuren University, Hangzhou, China. Electronic address: lanyingpan@zjsru.edu.cn.

Förderung

  • Key Research and Development Program of Sichuan Province
  • Fundamental Research Funds for the Provincial Universities of Zhejiang
  • National Natural Science Foundation of China

Zitieren

APA

Li, W., Cheng, Y., Wu, T., Zhao, C., Shao, Q., Pan, L., & Zheng, Y. (2026). Exploring the therapeutic potential of Anoectochilus roxburghii in glucose and lipid metabolism disorder: From phenotypic effects to molecular mechanisms and network pharmacology. Journal of Pharmaceutical and Biomedical Analysis. https://doi.org/10.1016/j.jpba.2026.117360

Vancouver

Li W, Cheng Y, Wu T, Zhao C, Shao Q, Pan L, et al. Exploring the therapeutic potential of Anoectochilus roxburghii in glucose and lipid metabolism disorder: From phenotypic effects to molecular mechanisms and network pharmacology. Journal of Pharmaceutical and Biomedical Analysis. 2026. doi:10.1016/j.jpba.2026.117360

BibTeX
@article{Li2026,
  author = {Li, Wei and Cheng, Yaqian and Wu, Tong and Zhao, Chenning and Shao, Qingsong and Pan, Lanying and Zheng, Ying},
  title = {Exploring the therapeutic potential of Anoectochilus roxburghii in glucose and lipid metabolism disorder: From phenotypic effects to molecular mechanisms and network pharmacology},
  journal = {Journal of Pharmaceutical and Biomedical Analysis},
  year = {2026},
  doi = {10.1016/j.jpba.2026.117360}
}
Kostenlos starten →